BioCentury
ARTICLE | Financial News

Arsanis raises $9.6 million

February 10, 2011 2:28 AM UTC

Arsanis Inc. (Vienna, Austria) raised $9.6 million in a series A round from OrbiMed Advisors; Polaris Venture Partners; and SV Life Sciences. Arsanis is focusing on developing mAbs against infectious diseases based on discovery technology from Adimab LLC (Lebanon, N.H.) . ...